Nuveen Asset Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.37M | Buy |
183,949
+13,048
| +8% | +$97.2K | ﹤0.01% | 2553 |
|
|
2024
Q3 | $1.37M | Buy |
170,901
+3,705
| +2% | +$29.6K | ﹤0.01% | 2616 |
|
|
2024
Q2 | $1.45M | Buy |
167,196
+10,623
| +7% | +$92.4K | ﹤0.01% | 2539 |
|
|
2024
Q1 | $3.24M | Buy |
156,573
+33,031
| +27% | +$683K | ﹤0.01% | 2175 |
|
|
2023
Q4 | $2.86M | Sell |
123,542
-52,320
| -30% | -$1.21M | ﹤0.01% | 2244 |
|
|
2023
Q3 | $1.41M | Buy |
175,862
+9,997
| +6% | +$79.9K | ﹤0.01% | 2438 |
|
|
2023
Q2 | $1.44M | Buy |
165,865
+62,067
| +60% | +$540K | ﹤0.01% | 2485 |
|
|
2023
Q1 | $305K | Sell |
103,798
-4,369
| -4% | -$12.8K | ﹤0.01% | 2915 |
|
|
2022
Q4 | $379K | Sell |
108,167
-7,234
| -6% | -$25.3K | ﹤0.01% | 2945 |
|
|
2022
Q3 | $913K | Sell |
115,401
-827
| -0.7% | -$6.54K | ﹤0.01% | 2794 |
|
|
2022
Q2 | $915K | Sell |
116,228
-7,632
| -6% | -$60.1K | ﹤0.01% | 2824 |
|
|
2022
Q1 | $1.58M | Buy |
123,860
+69,214
| +127% | +$885K | ﹤0.01% | 2619 |
|
|
2021
Q4 | $787K | Sell |
54,646
-6,912
| -11% | -$99.5K | ﹤0.01% | 2937 |
|
|
2021
Q3 | $680K | Sell |
61,558
-734
| -1% | -$8.11K | ﹤0.01% | 3110 |
|
|
2021
Q2 | $560K | Buy |
+62,292
| New | +$560K | ﹤0.01% | 3150 |
|
|
2020
Q2 | – | Sell |
-16,068
| Closed | -$164K | – | 3225 |
|
|
2020
Q1 | $164K | Buy |
16,068
+131
| +0.8% | +$1.34K | ﹤0.01% | 3017 |
|
|
2019
Q4 | $247K | Sell |
15,937
-156
| -1% | -$2.42K | ﹤0.01% | 3044 |
|
|
2019
Q3 | $292K | Hold |
16,093
| – | – | ﹤0.01% | 3054 |
|
|
2019
Q2 | $264K | Buy |
+16,093
| New | +$264K | ﹤0.01% | 3118 |
|